COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1866: Articles 18651-18660  | Next

Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
Haynes, W. A., Kamath, K., Lucas, C., Shon, J., Iwasaki, A.
10.1101/2021.01.06.20248960 — Posted: 2021-01-08 Discussion: Offsite
Quarantine fatigue thins fat-tailed coronavirus impacts in U.S. cities by making epidemics inevitable
Conte, M. N., Gordon, M., Sims, C.
10.1101/2021.01.07.21249366 — Posted: 2021-01-08
Socioeconomic Disparities in the Effects of Pollution on Spread of Covid-19: Evidence from US Counties
Allen, O., Brown, A., Wang, E.
10.1101/2021.01.06.21249303 — Posted: 2021-01-08
Knowledge, attitude, and practices regarding COVID-19: A study on workers from a food industry in Bangladesh.
Jubayer, M. F., Kayshar, M. S., Kabir, M. F., Limon, M. T. I., Al-Emran, M., Uddin, M. N.
10.1101/2021.01.06.21249118 — Posted: 2021-01-08
Blood omega-3 fatty acids and death from COVID-19: A Pilot Study
Asher, A., Tintle, N. L., Myers, M., Lockshon, L., Bacareza, H., Harris, W. S.
10.1101/2021.01.06.21249354 — Posted: 2021-01-08 Discussion: Onsite
Optimal design for phase 2 studies of SARS-CoV-2 antiviral drugs
Watson, J. A., Kissler, S., Day, N. P., Grad, Y. H., White, N. J.
10.1101/2021.01.06.21249368 — Posted: 2021-01-08
Modeling the effect of vaccination strategies in an Excel spreadsheet: The rate of vaccination, and not only the vaccination coverage, is a determinant for containing COVID-19 in urban areas
Alvarez, M. M., Bravo-Gonzalez, S., Trujillo-de Santiago, G.
10.1101/2021.01.06.21249365 — Posted: 2021-01-08
Inherent random fluctuations in COVID-19 outbreaks may explain rapid growth of new mutated virus variants
Bodin, K., Rocklov, J.
10.1101/2021.01.07.21249353 — Posted: 2021-01-08
SARS-CoV-2 patient self-testing with an antigen-detecting rapid test: a head-to-head comparison with professional testing
Lindner, A. K., Nikolai, O., Rohardt, C., Kausch, F., Wintel, M., Gertler, M., Burock, S., Hörig, M., Bernhard, J., Tobian, F., Gaeddert, M., Lainati, F., Corman, V. M., Jones, T. C., Sacks, J. A., Seybold, J., Denkinger, C. M., Mockenhaupt, F. P.
10.1101/2021.01.06.20249009 — Posted: 2021-01-08
Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection
Dalai, S. C., Dines, J. N., Snyder, T. M., Gittelman, R. M., Eerkes, T., Vaney, P., Howard, S., Akers, K., Skewis, L., Monteforte, A., Witte, P., Wolf, C., Nesse, H., Herndon, M., Qadeer, J., Duffy, S., Svejnoha, E., Taromino, C., Kaplan, I. M., Alsobrook, J., Manley, T., Baldo, L.
10.1101/2021.01.06.21249345 — Posted: 2021-01-08 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).